ha14-1 and naringenin
ha14-1 has been researched along with naringenin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Choi, BT; Choi, YH; Chung, KT; Jin, CY; Kim, GY; Kwon, TK; Lee, JH; Park, C | 1 |
Other Studies
1 other study(ies) available for ha14-1 and naringenin
| Article | Year |
|---|---|
Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzopyrans; Caspase Inhibitors; Cell Survival; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogen Antagonists; Flavanones; Humans; Leukemia; Membrane Potential, Mitochondrial; Mitochondria; Nitriles; Proto-Oncogene Proteins c-bcl-2; U937 Cells | 2009 |